antisense oligonucleotides ICAM-1 (Isis)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Nameantisense oligonucleotides ICAM-1 (Isis)

Drug Alias NameISIS-11158ISIS-17470ISIS-11159ISIS-16952ISIS-14725 +[6]

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionIntercellular adhesion molecule-1 inhibitorsAntisense oligonucleotide inhibitors

TargetsIntercellular adhesion molecule-1

Therapy Area/IndicationsInflammationNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIonis Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIonis Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A